Philadelphia Cardiovascular Summit featuring region’s leaders
December 4, 2017News Releases
The inaugural Philadelphia Cardiovascular Summit was held on November 17–18 at the Sofitel Philadelphia, featuring the region’s leading authorities in cardiovascular disease who discussed cutting-edge topics intended to advance the diagnosis and treatment of cardiovascular disease.
The Philadelphia Cardiovascular Summit was led by Konstadinos Plestis, MD, system chief of cardiothoracic and vascular surgery at Main Line Health, and William Gray, MD, system chief of cardiovascular disease at Main Line Health and president of Lankenau Heart Institute. The summit featured high-level, interactive content with educational lectures delivered by regional physicians who are nationally-recognized in the field of cardiology and cardiovascular surgery.
“We are proud to have created such a high-quality program in Philadelphia which brought some of the brightest minds in our profession and educated the more than 150 health care professionals who were in attendance,” says Plestis. “Our vision for organizing the summit was to deliver a comprehensive, multifaceted program that would advance cardiovascular patient care in the Philadelphia region and beyond.”
We were honored to have immediate past president of the Society of Thoracic Surgeons, Dr. Joseph Bavaria delivering the keynote speech. Dr. Bavaria discussed the current and future state of outcomes reporting in cardiovascular surgery and the impact on the profession during his session. Honorary speaker, Dr. Raymond Singer shared his personal journey through changes that have affected the way cardiovascular surgeons team up with their cardiologist colleagues.
“With topics ranging from innovative treatments for complex aortic disease, the latest in transcatheter aortic and mitral valve therapies, advances in the treatment of atrial fibrillation and the future of cardiac imaging, our program provided insights into the clinical and practical issues that health care professionals encounter on a daily basis,” adds Gray.
The Philadelphia Cardiovascular Summit brought together more than 35 physician experts who presented on the latest advancements and treatments in the field cardiovascular medicine and surgery. The faculty represented some of the Mid Atlantic region’s leading institutions including Main Line Health, Penn Medicine, Jefferson Health, and Temple University Hospital in Philadelphia; Lehigh Valley Health System in Allentown, Pennsylvania; Rutgers Health/Robert Wood Johnson, Lourdes Health System and Hackensack University Medical Center in New Jersey; and Lenox Hill Hospital, Weil-Cornell Medical Center and Mount Sinai Hospital in New York.
The CME program was organized by Main Line Health and Lankenau Heart Institute and was financially supported through educational grants and exhibits from industry partners.
For more information about Main Line Health’s Lankenau Heart Institute and cardiovascular services offered across the system, visit mainlinehealth.org/heart.
About Main Line Health
Founded in 1985, Main Line Health is a not-for-profit health system serving Philadelphia and its western suburbs. Main Line Health's commitment—to deliver advanced medicine for treating and curing disease, playing an important role in prevention and disease management as well as training physicians and other health care providers—reflects our intent to be the region's premier choice for clinical care, research, and education. A team of more than 10,000 employees, 3,000 nurses and 2,000 physicians care for patients throughout the Main Line Health System.
At Main Line Health's core are four of the region's most respected acute care hospitals—Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital—as well as one of the nation's premier facilities for rehabilitative medicine, Bryn Mawr Rehabilitation Hospital.
Main Line Health also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, which includes skilled home health care, hospice and home infusion services; Main Line Health Centers, primary and specialty care, lab and radiology, and other outpatient services located in Broomall, Collegeville, Concordville, Exton, King of Prussia and Newtown Square; Lankenau Institute for Medical Research, a biomedical research organization; and Main Line HealthCare, one of the region's largest multispecialty physician networks.
Main Line Health is the recipient of numerous awards for quality care, and service, including U.S. News & World Report's Best Hospitals, System Magnet® designation; the nation's highest distinction for nursing excellence and the Mid-Atlantic Alliance for Performance Excellence (MAAPE) Excellence Award. Main Line Health is committed to creating an environment of diversity, respect, equity, and inclusion, has proudly received awards in this area and has embraced the American Hospital Association's #123forEquity Pledge to Act to eliminate disparities in care. We are dedicated to advancing patient-centered care, education, and research to help patients stay healthy and live their best lives.
The Lankenau Heart Institute is Main Line Health’s premier, comprehensive cardiovascular medicine and surgery program. The Lankenau Heart Institute brings together the clinical expertise of all four Main Line Health acute care hospitals and community cardiology practices to ensure that patients receive a level of quality, service, and experience that is unprecedented in the region. Through the system-wide coordination of services, the Lankenau Heart Institute delivers preventive, diagnostic, therapeutic, and rehabilitative cardiovascular services at each of our locations including Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital.
Lankenau Heart Institute continues to be a pioneer in the use of beating-heart techniques and robotic-assisted procedures for coronary artery revascularization, minimally invasive and transcatheter approaches for valve repair and replacement, and complex aortic surgeries. With our growing experience and focus on minimally invasive techniques, Lankenau Heart Institute has expanded participation in clinical trials year over year. Our physicians are frequently invited to participate in clinical/medical device trials, many of these designed to facilitate minimally invasive procedures/approaches.
With a collaborative team of expert consultative cardiologists, interventional cardiologists, electrophysiologists, cardiovascular surgeons and specially trained nurses and technologists, the Lankenau Heart Institute is dedicated to managing and treating patients with heart failure, aortic disease, coronary and peripheral vascular disease, heart rhythm disorders and valve disease. Our team of cardiologists and cardiac specialists provide patients and their families with expert cardiac care, close to home.